A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the safety of Sabin Inactivated Poliovirus Vaccine (Vero cell)(sIPV)in the primary immunization of infants at the age of 2 months and booster immunization of children at the age of 18 months, and the simultaneous immunization with other vaccines of children at the age of 2 months and older, so as to provide reference for the improvement of immunization strategy.

Clinical Trial Description

This study is an open and observational phase Ⅳ clinical trial of Sabin Inactivated Poliovirus Vaccine.The purpose of this study is to evaluate the safety of Sabin Inactivated Poliovirus Vaccine (Vero cell)(sIPV)in the primary immunization of infants at the age of 2 months and booster immunization of children at the age of 18 months, and the simultaneous immunization with other vaccines of children at the age of 2 months and older, so as to provide reference for the improvement of immunization strategy.A total of 3200 subjects including 2000 subjects aged 2~3 months in primary immunization group,1200 subjects aged 18 months in primary immunization group will be enrolled and will receive sIPV vaccine or sIPV vaccine and other vaccines simultaneously. ;

Study Design

Related Conditions & MeSH terms

Poliomyelitis

Clinical Trial Details

NCT number	NCT05432141
Study type	Interventional
Source	Sinovac Biotech Co., Ltd
Contact
Status	Completed
Phase	Phase 4
Start date	June 13, 2022
Completion date	December 13, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04989231` - An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses
Completed	`NCT00352963` - Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).	Phase 3
Recruiting	`NCT03890497` - Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh	Phase 4
Completed	`NCT00753649` - Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants	Phase 4
Completed	`NCT04693286` - Clinical Trial of Novel OPV2 Vaccine	Phase 2
Completed	`NCT02847026` - Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study	Phase 4
Completed	`NCT02189811` - Polio End-game Strategies - Poliovirus Type 2 Challenge Study	Phase 4
Completed	`NCT01444781` - Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants	Phase 3
Completed	`NCT01214889` - Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.	Phase 3
Completed	`NCT00879827` - Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants	Phase 3
Completed	`NCT01457495` - Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly	Phase 2
Completed	`NCT02853929` - Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery	Phase 4
Completed	`NCT03614702` - Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV	Phase 3
Terminated	`NCT04063150` - Immunogenicity of Intramuscular and Intradermal IPV	Phase 4
Completed	`NCT04614597` - A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China
Completed	`NCT03239496` - A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV	Phase 3
Completed	`NCT04544787` - A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates	Phase 2
Completed	`NCT02985320` - Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine	Phase 1/Phase 2
Completed	`NCT02274285` - DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants	Phase 3
Completed	`NCT02291263` - Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine	Phase 3